-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As an innovative biotechnology leader, Fluidigm (Nasdaq: FLDM) has long been committed to improving people's lives through comprehensive health insights
The introduction of Biomark X makes the work process more simplified, the operation is more convenient, the manual operation time is less, the work efficiency is higher, and more data can be run at a time, so that the results can be obtained in a shorter time
"When using RT-PCR for R&D and applied research, the accuracy and reproducibility of data are extremely important
"There are currently many clinical laboratories, including pharmaceuticals, cooperative research organizations, and academic laboratories, fighting on the front line of fighting diseases and emerging pathogens.
"The equipment is expected to begin delivery in the first quarter of 2022.
Biomark X is a multifunctional system that can easily perform a variety of application research, including genotyping, sample identification, strain identification, conservation biology, personal genomics, gene expression, pathogen detection, pharmacogenomic analysis, and transplantation Prognosis and so on
For more FLUIDIGM product information, please contact:
Furuda (Shanghai) Instrument Technology Co.